A Study of Bevacizumab (Avastin) in Neoadjuvant Therapy in Participants With International Federation of Gynecology and Obstetrics (FIGO) Stage IIIC/IV Ovarian, Tubal, or Peritoneal Cancer, Initially Unresectable
Clinical trial NCT01739218 · COMPLETED
Trial details
- NCT number
- NCT01739218
- Sponsor
- Hoffmann-La Roche
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2013-02-01
- Primary completion
- 2016-08-17
- Enrollment
- 99
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.